{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Clinical Utility of Inflammatory and Genetic Biomarkers for Cardiovascular Disease Prevention, Categorization, and Treatment
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize the pathophysiology of the atherogenic triad as it relates to the continuum of vascular/ endothelium inflammation in ASCVD.
- Explain the utility of ASCVD-related inflammatory and genetic biomarkers in ASCVD risk stratification.
- Describe traditional and proposed risk stratification models for ASCVD.
Learning Outcomes
Seventy-five percent of participants will demonstrate knowledge of the pathophysiology, risk factor classification, and existing inflammatory and genetic biomarkers associated with atherosclerotic cardiovascular disease (ASCVD) by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
All authors and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$12.95
Credits:
- AANP 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
This Activity is approved for 1.0 contact hour (s) of continuing education by the American Association of Nurse Practitioners. Activity ID# 23066183.
This Activity was planned in accordance with AANP Accreditation Standards and Policies.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JAANP0723
Published: Jul 2023
Expires: 7/1/2024
Required Passing Score: 7/10 (70%)